Skip to Main Content

Author Details

Guido Davidzon
Stanford University
2005
68
22
PMIDPaper TitleJournal TitlePublished Year
37259967Predicting FDG-PET Images From Multi-Contrast MRI Using Deep Learning in Patients With Brain Neoplasms.J Magn Reson Imaging2024
38071587Early-Frame [<sup>18</sup>F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [<sup>15</sup>O]Water Gold Standard.J Nucl Med2024
36328488A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy.J Nucl Med2023
37591771Generative Adversarial Network-Enhanced Ultra-Low-Dose [<sup>18</sup>F]-PI-2620 Ï¿ PET/MRI in Aging and Neurodegenerative Populations.AJNR Am J Neuroradiol2023
37555901Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.Eur J Nucl Med Mol Imaging2023
36396456A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer.J Nucl Med2023
36934603Reductions in synaptic marker SV2A in early-course Schizophrenia.J Psychiatr Res2023
36869177SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post <sup>177</sup>Lu-DOTATATE and <sup>177</sup>Lu-PSMA617 setting.Eur J Nucl Med Mol Imaging2023
34747986Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab.JAMA Neurol2022
35641196Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.Oncologist2022
35552245Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer.J Nucl Med2022
35512996<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment.J Nucl Med2022
36371232Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease.Alzheimers Res Ther2022
35052839Phenotypic Heterogeneity among <i>GBA</i> p.R202X Carriers in Lewy Body Spectrum Disorders.Biomedicines2022
34823095<sup>68</sup>Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors.Transl Oncol2022
32789649Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy.Mol Imaging Biol2021
33547210Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy.J Nucl Med2021
33767174Multi-task weak supervision enables anatomically-resolved abnormality detection in whole-body FDG-PET/CT.Nat Commun2021
33903986Increasing Diversity in Radiology and Molecular Imaging: Current Challenges.Mol Imaging Biol2021
33674398PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.J Nucl Med2021
33509370Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images.Semin Nucl Med2021
34521985Author Correction: Low-count whole-body PET with deep learning in a multicenter and externally validated study.NPJ Digit Med2021
34426629Low-count whole-body PET with deep learning in a multicenter and externally validated study.NPJ Digit Med2021
34475101A Clinical PET Imaging Tracer ([[18]F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma.Clin Cancer Res2021
34070751Results of a Prospective Trial to Compare <sup>68</sup>Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors.Diagnostics (Basel)2021
33408146Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease.Neurology2021
33416955True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation.Eur J Nucl Med Mol Imaging2021
33469884The Clinical Utility of <sup>18</sup>F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval.Mol Imaging Biol2021
32918110An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [<sup>18</sup>F]FDG PET/CT.Eur J Nucl Med Mol Imaging2021
32572562Tau PET imaging with <sup>18</sup>F-PI-2620 in aging and neurodegenerative diseases.Eur J Nucl Med Mol Imaging2021
31628216Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management.J Nucl Med2020
31938892Human biodistribution and radiation dosimetry of [<sup>18</sup>F]DASA-23, a PET probe targeting pyruvate kinase M2.Eur J Nucl Med Mol Imaging2020
31659587Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans.J Digit Imaging2020
32296882Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy.Eur J Nucl Med Mol Imaging2020
32535655Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning.Eur J Nucl Med Mol Imaging2020
32556481Deep learning detection of prostate cancer recurrence with <sup>18</sup>F-FACBC (fluciclovine, Axumin®) positron emission tomography.Eur J Nucl Med Mol Imaging2020
31562226Comparison of 3 Interpretation Criteria for <sup>68</sup>Ga-PSMA11 PET Based on Inter- and Intrareader Agreement.J Nucl Med2020
30854452[18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.Tomography2019
31768196Fungal endocarditis resembling primary cardiac malignancy in a patient with B-cell ALL with culture confirmation.Radiol Case Rep2019
31526257Bone Marrow and Tumor Radiomics at <sup>18</sup>F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer.Radiology2019
31350603Prognostic value of somatostatin receptor expressing tumor volume calculated from <sup>68</sup>Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors.Eur J Nucl Med Mol Imaging2019
31456863<sup>18</sup>F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma.Nucl Med Mol Imaging2019
31568189Initial experience with a PET/computed tomography system using silicon photomultiplier detectors.Nucl Med Commun2019
29076913Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma.Clin Nucl Med2018
29700130Embrace Progress.J Nucl Med2018
29666972Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality.EJNMMI Phys2018
2858247218F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.PLoS One2017
27998877Bridging the Health Data Divide.J Med Internet Res2016
24355259NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.Lung Cancer2014
24956051Case 207: Hodgkin lymphoma with paraneoplastic hypercalcemic pancreatitis.Radiology2014
  • 1 - 50 of 68

Recommended Authors

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Vincent Dunet
Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 0
Michael A Morris
Clinical Center, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 0
Zhifang Wu
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 1
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 0
Babak Saboury
Clinical Center
Career Start Year 2006
Number of shared co-authors 0
Eugene Jeong
Vanderbilt University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Arman Rahmim
BC Cancer Research Institute, University of British Columbia
Career Start Year 2004
Number of shared co-authors 0
Li-Ping Fu
Peking University
Career Start Year 2002
Number of shared co-authors 0
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 1
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 0
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Lance T Hall
University of Wisconsin Hospitals and Clinics
Career Start Year 1998
Number of shared co-authors 0
Winnie Wing-Chuen Lam
Singapore General Hospital
Career Start Year 1997
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 0
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Elizabeth C Jones
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 0
Johannes Czernin
university of california los angeles
Career Start Year 1987
Number of shared co-authors 0
John J Sunderland
University of Iowa
Career Start Year 1986
Number of shared co-authors 1
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year 1986
Number of shared co-authors 4
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 1
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 0
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 1
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Leo Anthony Celi
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 3
David R Thorburn
Co-authored papers 3
Thomas J Montine
Stanford University
Co-authored papers 2
Bhavik N Patel
Gold Coast University Hospital
Co-authored papers 1
Dominic C Marshall
National Heart and Lung Institute
Co-authored papers 1
Mark K Buyyounouski
Stanford University
Co-authored papers 1
Daniel L Rubin
Stanford University.
Co-authored papers 1
Bonnie Berger
Massachusetts Institute of Technology
Co-authored papers 1
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 1
Esko Wiltshire
Co-authored papers 1
William C Copeland
National Institute of Environmental Health Sciences, National Institutes of Health
Co-authored papers 1
Angus C Nairn
Co-authored papers 1
Matthew P Lungren
Inc., University of California san francisco
Co-authored papers 1
Ronald G Haller
Co-authored papers 1
Mark A Tarnopolsky
McMaster University Medical Center
Co-authored papers 1
Alistair E W Johnson
The Hospital for Sick Children
Co-authored papers 1
Justin D Salciccioli
Brigham and Women's Hospital
Co-authored papers 1
Joon Lee
Cumming School of Medicine, University of Calgary
Co-authored papers 1
Tom J Pollard
Massachusetts Institute of Technology, Scientific Data - Nature, Software Sustainability Institute, University College London, University of Law - London Bloomsbury Centre
Co-authored papers 1
Denise M Kirby
Co-authored papers 1
Kimberly Kallianos
University of California San Francisco
Co-authored papers 1
Francisco Muge Salgueiro
Co-authored papers 1
Daniel J Scott
Massachusetts Institute of Technology
Co-authored papers 1
Hilary P Bagshaw
Stanford University
Co-authored papers 1
Babett Lind
Portland VA Medical Center
Co-authored papers 1
Mauricio Villarroel
Institute of Biomedical Engineering, University of Oxford
Co-authored papers 1
Henry C Chueh
Massachusetts General Hospital
Co-authored papers 1
William T Lester
Massachusetts General Hospital
Co-authored papers 1
Douglas F Levinson
Stanford University School of Medicine
Co-authored papers 1
Chirag J Patel
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2